Relapsing-remitting multiple sclerosis (RRMS)

Clinical trials for Relapsing-remitting multiple sclerosis (RRMS) explained in plain language.

Never miss a new study

Get alerted when new Relapsing-remitting multiple sclerosis (RRMS) trials appear

Sign up with your email to follow new studies for Relapsing-remitting multiple sclerosis (RRMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 5 Not yet finished but already full! 4 Completed 1

Could your own blood cells tame MS? early trial shows promise

Disease control Completed

This early-phase trial tested a new treatment for relapsing-remitting multiple sclerosis (RRMS) that uses a patient's own red blood cells. The cells are coated with specific peptides and given back to the patient to teach the immune system to stop attacking the body. The study in…

Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)

Phase 1 • Sponsor: Cellerys AG • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC

Relapsing-remitting multiple sclerosis (RRMS)

Get alerted when new Relapsing-remitting multiple sclerosis (RRMS) trials appear

Could your own blood cells tame MS? early trial shows promise